The Registry of Toxic Effects of Chemical Substances
Toluene - 2,4 - diamine |
UPDATE: May 2005 | MW: 122.19 | MF: C7H10N2 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
100 mg/24 hour
|
moderate
|
85JCAE -,477,1986
|
eye | rabbit
100 mg/24 hour
|
moderate
|
TAEHC* IP:74,1,1987
|
skin | rabbit
500 mg/24 hour
|
mild
|
85JCAE -,477,1986
|
skin | rabbit
500 mg/24 hour
|
mild
|
TAEHC* IP:75,1,1987
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
body fluid assay
|
rat
| Salmonella typhimurium
70 mg/kg
|
JJIND8 76,291,1986
|
cytogenetic analysis
|
hamster
ovary
|
4 mmol/L
|
MUREAV 265,45,1992
|
DNA adduct
|
oral | rat
84 mg/kg/3 week- continuous
|
MUREAV 367,209,1996
|
DNA damage
|
human
fibroblast
|
100 µmol/L
|
MUREAV 127,107,1984
|
DNA damage
|
intraperitoneal | mouse
240 mg/kg
|
MUREAV 391,201,1997
|
DNA damage
|
oral | mouse
60 mg/kg
|
MUREAV 440,1,1999
|
DNA damage
|
intraperitoneal | rat
37 mg/kg
|
CRNGDP 6,1285,1985
|
DNA inhibition
|
intraperitoneal | mouse
111 mg/kg
|
MUREAV 91,75,1981
|
unscheduled DNA synthesis
|
human
liver
|
100 µmol/L
|
CNREA8 49,1075,1989
|
unscheduled DNA synthesis
|
oral | rat
150 mg/kg
|
ENMUDM 4,553,1982
|
unscheduled DNA synthesis
|
rat
liver
|
10 µmol/L
|
MUREAV 315,147,1994
|
mutation in microorganisms
|
Salmonella typhimurium
|
10 mg/plate (+enzymatic activation step)
|
ENMUDM 5(Suppl 1),3,1983
|
mutation in microorganisms
|
Salmonella typhimurium
|
10 µg/plate (-enzymatic activation step)
|
JJIND8 76,291,1986
|
micronucleus test
|
oral | rat
300 mg/kg
|
CRNGDP 12,2233,1991
|
mutation in mammalian somatic cells
|
hamster
ovary
|
2 gm/L
|
MUREAV 135,115,1984
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
198 mg/L
|
MUREAV 135,115,1984
|
morphological transform
|
hamster
embryo
|
500 µg/L
|
CALEDQ 3,45,1977
|
morphological transform
|
mouse
fibroblast
|
10 mg/L/21 day (-enzymatic activation step)
|
EMMUEG 35,300,2000
|
other mutation test systems
|
hamster
ovary
|
6 mmol/L
|
MUREAV 265,45,1992
|
other mutation test systems
|
Salmonella typhimurium
|
60 mg/L
|
MUREAV 192,239,1987
|
phage inhibition capacity
|
Escherichia coli
|
100 mmol/L
|
MDMIAZ 31,11,1979
|
sister chromatid exchange
|
intraperitoneal | mouse
9 mg/kg
|
MUREAV 108,225,1983
|
sex chromosome loss and nondisjunction
|
parenteral | Drosophila melanogaster
5 mmol/L
|
MUREAV 56,31,1977
|
sex chromosome loss and nondisjunction
|
oral | Drosophila melanogaster
15,200 mmol/L/3 day
|
MUREAV 48,181,1977
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 1,200 mg/kg (6-13 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on newborn: Live birth index (Litter size (e.g., # fetuses per litter; measured after birth)
TCMUD8 7,29,1987
|
oral | rat
lowest published toxic dose: 1,260 mg/kg (10 week male)
|
Reproductive: Effects on fertility: Mating performance (e.g., # sperm positive females per # females mated; # copulations per # estrus cycles)
|
JTEHD6 16,753,1985
|
oral | rat
lowest published toxic dose: 1,260 mg/kg (10 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands
JTEHD6 16,763,1985
|
oral | rat
lowest published toxic dose: 210 mg/kg (1 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct
JTEHD6 25,435,1988
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 8,050 mg/kg/101 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Blood: Lymphoma including Hodgkin's disease
NCITR* NCI-TR-162,1979
|
oral | mouse
toxic dose : 17 gm/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Blood: Lymphoma including Hodgkin's disease
NCITR* NCI-TR-162,1979
|
oral | mouse
toxic dose : 8,400 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
GANNA2 70,453,1979
|
oral | mouse
toxic dose : 16,800 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
GANNA2 70,453,1979
|
oral | rat
lowest published toxic dose: 2,100 mg/kg/90 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Skin and Appendages: Tumors
JJIND8 62,1107,1979
|
oral | rat
toxic dose : 5,030 mg/kg/84 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Blood: Lymphoma including Hodgkin's disease
NCITR* NCI-TR-162,1979
|
oral | rat
toxic dose : 9,000 mg/kg/36 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
CNREA8 29,1137,1969
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 480 mg/kg
|
N/R
|
JEPTDQ 3(1-2),149,1979
|
intraperitoneal | rat
lethal dose (50 percent kill): 325 mg/kg
|
N/R
|
JEPTDQ 3(1-2),149,1979
|
oral | rat
lethal dose (50 percent kill): 590 mg/kg/24 hour
|
N/R
|
TAEHC* -,1,1987
|
subcutaneous | dog
lowest published lethal dose: 200 mg/kg
|
N/R
|
XPHBAO 271,56,1941
|
subcutaneous | rat
lowest published lethal dose: 350 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Cardiac: Pulse rate decreased with fall in BP Lung, Thorax, or Respiration: Respiratory stimulation
ZEPTAT 17,59,1915
|
subcutaneous | rabbit
lowest published lethal dose: 400 mg/kg
|
Brain and Coverings: Other degenerative changes | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Respiratory stimulation
ZEPTAT 17,59,1915
|
skin | rabbit
lethal dose (50 percent kill): 650 mg/kg/24 hour
|
N/R
|
TAEHC* -,1,1987
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 36,500 mg/kg/2 year- intermittent
|
Kidney, Ureter, and Bladder: Other changes | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TAEHC* -,1,1987
|
oral | rat
lowest published toxic dose: 1,050 mg/kg/70 day - continuous
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands
TAEHC* IP:74,67,1987
|
oral | rat
lowest published toxic dose: 350 mg/kg/5 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
|
TAEHC* -,1,1987
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 16,83,1978
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human No Adequate Data
|
IMEMDT 16,83,1978
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2B
|
IMSUDL 7,56,1987
|
TOXICOLOGY REVIEW
|
|
MUREAV 543,201,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,227,2004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - AUSTRIA
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - FINLAND
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - GERMANY
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 0.04 mg/m3, MAC(short term exposure limit) 0.1 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 2 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
Carcinogen, JAN1993
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.1 mg/m3, Carcinogen, JAN1999
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO TOLUENEDIAMINE-air
|
Carcinogen lowest feasible concentration
|
NIOSH* DHHS #92-100,1992
|
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X5386; |
Number of Industries 6; Total Number of Facilities 130; Number of Occupations 15; Total Number of Employees Exposed 8,511; Total Number of Female Employees Exposed 396 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; Histidine reversion-Ames test
|
EPA GENETOX PROGRAM 1988, Positive: D melanogaster Sex-linked lethal
|
EPA GENETOX PROGRAM 1988, Negative: N crassa-aneuploidy; Sperm morphology-mouse
|
EPA GENETOX PROGRAM 1988, Inconclusive: SHE-clonal assay
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as an intermediate in the production of POLYURETHANE, and to make dyes for textiles, fur
|
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, PROPOSED RULE
|
FEREAC 47,27009,82
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 53, DECEMBER 1989
|
NIOSH Analytical Method, 1994: 2,4-Toluenediamine, 5516
|
NCI Carcinogenesis Bioassay (feed);clear evidence:mouse,rat
|
NCITR* NCI-TR-162,1979
|
NTP 11th Report on Carcinogens,2004:Reasonably anticipated to be a human carcinogen
|
NTP Carcinogenesis studies; test completed (peer review), October 2000
|
OSHA ANALYTICAL METHOD #ID-65
|
|
REFERENCES:
CODEN
|
|
REFERENCE
85JCAE
|
"Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia,
Avicenum, 1986
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
GANNA2
|
Gann. Japanese Journal of Cancer Research. (Tokyo, Japan) V.1-75, 1907-84. For publisher
information, see JJCREP.
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
IMSUDL
|
IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY
12210) No.1- 1979-
|
JEPTDQ
|
Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3),
1977-81(?). For publisher information, see JEPOEC.
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MDMIAZ
|
Medycyna Doswiadczalna i Mikrobiologia. For English translation, see EXMMAV. (Ars Polona,
POB 1001, 00-068 Warsaw 1, Poland) V.1- 1949-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NCITR*
|
National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205.
For publisher information, see NTPTR*.
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
TAEHC*
|
Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health
Organization) 1- 1976-
|
TCMUD8
|
Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New
York, NY 10003) V.1- 1980-
|
XPHBAO
|
U.S. Public Health Service, Public Health Bulletin. (Washington, DC)
|
ZEPTAT
|
Zeitschrift fuer Experimentelle Pathologie und Therapie. (Berlin, Ger.) V.1-22, 1905-21. For
publisher information, see REXMAS.
|
|